News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Janssen-Cilag International NV (JNJ) Release: New and Long-Term Use Results for Canagliflozin to be Presented at European Association for the Study of Diabetes Annual Meeting



9/18/2013 10:09:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV (Janssen) announced today that 12 presentations on canagliflozin will be made at the upcoming annual meeting of the European Association for the Study of Diabetes (EASD), from September 24-27 in Barcelona, Spain.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES